VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 134 filers reported holding VIKING THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $909 | +599.2% | 82,099 | +924.4% | 0.01% | +900.0% |
| Q2 2023 | $130 | +30.0% | 8,014 | -25.0% | 0.00% | 0.0% |
| Q4 2022 | $100 | -100.0% | 10,684 | -86.5% | 0.00% | -50.0% |
| Q1 2022 | $237,000 | -43.8% | 78,850 | -14.1% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | -31.4% | 91,797 | -6.3% | 0.00% | -33.3% |
| Q3 2021 | $615,000 | +742.5% | 98,009 | +708.2% | 0.00% | – |
| Q2 2021 | $73,000 | -89.7% | 12,127 | -90.4% | 0.00% | -100.0% |
| Q4 2020 | $710,000 | -59.8% | 126,106 | -58.4% | 0.00% | -63.6% |
| Q3 2020 | $1,765,000 | +255.1% | 303,228 | +339.8% | 0.01% | +175.0% |
| Q2 2020 | $497,000 | -38.9% | 68,940 | -60.3% | 0.00% | -50.0% |
| Q1 2020 | $813,000 | +69.0% | 173,732 | +189.7% | 0.01% | +100.0% |
| Q4 2019 | $481,000 | -72.1% | 59,966 | -76.1% | 0.00% | -71.4% |
| Q3 2019 | $1,726,000 | +688.1% | 250,884 | +849.3% | 0.01% | +600.0% |
| Q2 2019 | $219,000 | +76.6% | 26,428 | +62.9% | 0.00% | +100.0% |
| Q4 2018 | $124,000 | -76.4% | 16,221 | -46.2% | 0.00% | -75.0% |
| Q3 2018 | $526,000 | – | 30,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |